KLK3 and prostate carcinoma: Androgen deprivation therapy (ADT) is the key treatment for advanced prostate cancer patients or patients with high serum prostate-specific antigen levels with intermediate or high-risk prostate cancer even without imaging findings or other evidence of disseminated disease [1, 2].